RecruitingNot ApplicableNCT06880406

Mitochondrial Function and Metabolomic Profile in Alzheimer's Disease and Related Dementias

Early Alterations of Peripheral Mitochondrial Function and Metabolomic Profile in Patients With Alzheimer's Disease and Related Dementias


Sponsor

Centre Hospitalier Universitaire de Nice

Enrollment

170 participants

Start Date

Jul 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This project aims to study on one hand the early mitochondrial alterations, common or specific, occurring in peripheral cells of patients with Alzheimer's disease or related dementia and, on the other hand, identify the metabolomic biomarkers that may be at the origin of mitochondrial disturbances associated with the disease. This will be the first study combining functional analyses of mitochondria and exploratory metabolomic assessments in the same cohort at early stages of the disease.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study investigates how the mitochondria (the energy-producing parts of cells) function differently in people with Alzheimer's disease and other types of dementia. Researchers will study energy metabolism and biological markers in the blood and spinal fluid to better understand what drives these conditions at a cellular level. **You may be eligible if:** - You have a cognitive disorder (memory or thinking problems) that has been present or reported for at least 6 months - Your diagnosis is being evaluated according to current medical guidelines - You have had cerebrospinal fluid (spinal fluid) biomarker testing done at the study center and agreed to provide biological samples **You may NOT be eligible if:** - Your cognitive symptoms have only recently started (less than 6 months) - You have not had the required diagnostic workup - You are unwilling to undergo the biological sample collection procedures - You have a condition that prevents safe spinal fluid collection Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMMSE and blood draw

Each patient will be evaluated by Mini-Mental State Examination (MMSE) and will have a blood draw


Locations(1)

CHU de Nice

Nice, PACA, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06880406


Related Trials